MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Irritable bowel syndrome is more prevalent than functional constipation in Parkinson’s disease: Clinical spectrum and changes in gut microbiota

    T. Mertsalmi, V. Aho, P.A.B. Pereira, L. Paulin, E. Pekkonen, P. Auvinen, F. Scheperjans (Helsinki, Finland)

    Objective: To assess distal functional gastrointestinal (GI) symptoms and their connection to fecal microbiota (FM) in Parkinson (PD) patients. Background: The majority of PD patients…
  • 2016 International Congress

    Bradykinesia of external urethral sphincter in a Patient with Parkinson’s disease: Case report

    I.E. Estrada-Bellmann, A. Gutierrez, H.J. Villarreal, J.J. Peña, D. Ortiz (Monterrey, Mexico)

    Objective: The aim of this paper is to present a case and its assessment and management. Background: The bladder dysfunction is one of the most…
  • 2016 International Congress

    Risks and predictive factors for pneumonia amongst Parkinson’s disease patients with dysphagia

    K.H. Goh, H.L. Ng, K.Y. Tay, S. Acharyya, S.Y.E. Ng, J.P.L. Boo, A.H.J. Kooi, W. Li, W.L. Au, L.C.S. Tan (Singapore, Singapore)

    Objective: To evaluate (1) Time to hospitalisation for pneumonia/choking in Parkinson's disease (PD) patients. (2) Demographic and clinical features that associated with pneumonia/choking. Background: Dysphagia…
  • 2016 International Congress

    Clinical profile and outcome of hospitalized patients with Parkinson’s disease

    P. Chatterjee, K. Chatterjee, R. Banerjee, S. Choudhury, B. Mondal, M. Ummekulsum, S.S. Jha, S. Chatterjee, S.S. Anand, H. Kumar (Kolkata, India)

    Objective: In this study we explored the cause of hospitalization, clinical course and outcome among Parkinson's disease (PD) patients. Background: Patients with PD are frequently…
  • 2016 International Congress

    Characterization of sleep disturbances in a prospective population-based cohort to investigate Parkinson’s disease

    S. Tunc, J. Hampf, E.J. Vollstedt, K. Hückelheim, E. Warrlich, C. Kritzinger, C. Bibergeil, J. Graf, C. Klein, M. Kasten (Lübeck, Germany)

    Objective: To study sleep disturbances in Parkinson's disease (PD) in a prospective population-based cohort. Background: Sleep disturbances such as daytime sleepiness are frequent in PD.…
  • 2016 International Congress

    Prevalence and risk factors of orthostatic hypotension in Thai Parkinson’s disease patients

    S. Klanbut, S. Wongwiwatthananukit, C. Suthisisang, R. Bhidayasiri, S. Phattanarudee (Bangkok, Thailand)

    Objective: To determine the prevalence of OH and identify risk factors associated with OH in Thai PD patients. Background: Orthostatic hypotension (OH) represents one of…
  • 2016 International Congress

    Anxiolytic-like activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) in rodent models of anxiety

    K. Yamada, M. Kobayashi, J. Kase, A. Mori, P. Jenner, T. Kanda (Shizuoka, Japan)

    Objective: The aim of this study was to assess the anxiolytic effects of istradefylline (KW-6002), an adenosine A2A receptor antagonist, in naive and anxiety-prone animals…
  • 2016 International Congress

    Anxiety in patients with Parkinson’s disease

    K. Zhu, J.J. van Hilten, J. Marinus (Leiden, Netherlands)

    Objective: The aim of this longitudinal study is to examine which factors are associated with longitudinal changes in anxiety levels among individuals with Parkinson's disease…
  • 2016 International Congress

    Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson’s disease diagnosis

    M. Rossi, C. Terroba Chambi, A. Bril, P. Millar Vernetti, D. Cerquetti, A. Cammarota, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the diagnostic value of combined acute levodopa challenge and olfactory testing to predict PD diagnosis. Background: Acute levodopa challenge can be used…
  • 2016 International Congress

    Alpha-synuclein aggregates of cardiac sympathetic nerves in synucleinopathies and in neurologically unimpaired subjects. Correlation with sympathetic denervation

    M. Carmona-Abellán, I. Marcilla, I. Martínez-Valbuena, T. Tuñón, R. Luquin-Piudo (Pamplona, Spain)

    Objective: To study the cardiac sympathetic innervation and its relationship with the incidence of alpha-synuclein deposits in heart tissue of synucleinopathies and asymptomatic control patients.…
  • « Previous Page
  • 1
  • …
  • 1379
  • 1380
  • 1381
  • 1382
  • 1383
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley